{"id":490149,"date":"2010-03-30T15:08:55","date_gmt":"2010-03-30T19:08:55","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=70968"},"modified":"2010-03-30T15:08:55","modified_gmt":"2010-03-30T19:08:55","slug":"3-6m-for-biocept","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/490149","title":{"rendered":"$3.6M for Biocept"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Biotech\/\">Biotech<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/deals\/\">deals<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/funding\/\">funding<\/a><\/div>\n<p>\t\t<strong>Erin Kutz wrote:<\/strong><\/p>\n<p><a href=\"http:\/\/www.biocept.com\/\">Biocept<\/a>, a San Diego biotech company working on cell separation technology, has raised $3.6 million of a planned $4.05 million equity offering, according to an SEC <a href=\"http:\/\/www.sec.gov\/Archives\/edgar\/data\/1044378\/000104437810000001\/xslFormDX01\/primary_doc.xml\">filing<\/a>. Four investors participated in the round for Biocept, which is developing diagnostic assays for detecting and monitoring cancer.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/san-diego\/2010\/03\/30\/3-6m-for-biocept\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20$3.6M%20for%20Biocept%20http:\/\/xconomy.com\/?p=70968\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/san-diego\/2010\/03\/30\/3-6m-for-biocept\/&#038;t=$3.6M%20for%20Biocept\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/san-diego\/2010\/03\/30\/3-6m-for-biocept\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=%243.6M+for+Biocept&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fsan-diego%2F2010%2F03%2F30%2F3-6m-for-biocept%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=ade712d17b7e266e9376a4d7bb99bee6&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=ade712d17b7e266e9376a4d7bb99bee6&#038;p=1\"\/><\/a><br \/>\n<!-- foo --><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/D886Je2DunE3dy7a2olXVcGPkDg\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/D886Je2DunE3dy7a2olXVcGPkDg\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/D886Je2DunE3dy7a2olXVcGPkDg\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/D886Je2DunE3dy7a2olXVcGPkDg\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/1Jgu5nQg5Ww\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech, deals, funding Erin Kutz wrote: Biocept, a San Diego biotech company working on cell separation technology, has raised $3.6 million of a planned $4.05 million equity offering, according to an SEC filing. Four investors participated in the round for Biocept, which is developing diagnostic assays for detecting and monitoring cancer. Comments | Reprints | [&hellip;]<\/p>\n","protected":false},"author":1661,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-490149","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/490149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1661"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=490149"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/490149\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=490149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=490149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=490149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}